Crossmark

Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial)

Crossref DOI link: https://doi.org/10.1186/s12903-024-04379-3

Published Online: 2024-06-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elsaadany, Basma

Anayb, Samah M.

Mashhour, Karim

Yossif, Mohammed

Zahran, Fat’heya
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2024-06-01

Version of Record valid from 2024-06-01
More Information

Article History

Received: 12 August 2023

Accepted: 16 May 2024

First Online: 1 June 2024

Declarations

:

: The study performed in accordance with the Declaration of Helsinki, the protocol was approved by the Ethics Committee of Scientific Research, Faculty of Dentistry, Cairo University [approval no191113].The aim of the study was explained to all subjects participating in this study and written informed consents were obtained before enrolment.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below